Gemcitabine Plus Cisplatin With or Without M7824 in Participants With 1L Biliary Tract Cancer (BTC)

Conditions:   Biliary Tract Cancer;   Cholangiocarcinoma;   Gallbladder Cancer Interventions:   Drug: M7824;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Cisplatin Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials